USA300 Staphylococcus aureus persists on multiple body sites following an infection

Background

USA300 methicillin-resistant Staphylococcus aureus (MRSA) is a community- and hospital-acquired pathogen that frequently causes infections but also can survive on the human body asymptomatically as a part of the normal microbiota. We devised a comparative genomic strategy to track colonizing USA300 at different body sites after an initial infection. We sampled ST8 S. aureus from subjects at the site of a first known MRSA infection. Within 60 days of this infection and again 12 months later, each subject was tested for asymptomatic colonization in the nose, throat and perirectal region. 93 S. aureus strains underwent whole genome shotgun sequencing.

Results

Among 28 subjects at the initial sampling time, we isolated S. aureus from the nose, throat and perirectal sites from 15, 11 and 15 of them, respectively. Twelve months later we isolated S. aureus from 9 subjects, with 6, 3 and 3 strains from the nose, throat and perirectal area, respectively. Genome sequencing revealed that 23 patients (ages 0–66 years) carried USA300 intra-subject lineages (ISLs), defined as having an index infection isolate and closely related colonizing strains. Pairwise distance between strains in different ISLs was 48 to 162 single nucleotide polymorphisms (SNPs) across the core regions of the chromosome, whereas within the same ISL it was 0 to 26 SNPs. Strains in ISLs from the same subject differed in plasmid and prophage content, and contained deletions that removed the mecA-containing SCCmec and ACME regions. Five strains contained frameshift mutations in agr toxin-regulating genes. Persistence of an ISL was not associated with clinical or demographic subject characteristics. We inferred that colonization with the ISL occurred about 18 weeks before the first assessment of asymptomatic colonization.

Conclusions

Clonal lineages of USA300 may continue to colonize people at one or more anatomic sites up to a year after an initial infection and experience loss of the SCCmec, loss and gain of other mobile genetic elements, and mutations in the agr operon.

Staphylococcus aureus is one of the most common human bacterial pathogens, causing skin and soft tissue infections (SSTI), bacteremia, osteomyelitis and other disseminated infections [1]. While it can be deadly, S. aureus is more commonly a commensal species, living on the skin, the mucous membranes, and in the gut [2] of 25–50% of the human population [3]. Since the 1940s, the species has evolved resistance to each class of antibiotics introduced to treat infections [4]. Resistance to β-lactam antibiotics due to the expression of altered penicillin-binding protein PBP2a, encoded by mecA and mecC genes located in a mobile genetic element called SCCmec [5, 6], has been a particularly vexing problem. Strains that contain PBP2a, known as methicillin-resistant S. aureus (MRSA), have proliferated since being first reported in 1961 in the United Kingdom [7, 8].

Previous studies have demonstrated differences in fitness and virulence between genetic backgrounds of MRSA [9,10,11]. One genotype of MRSA, USA300, emerged in the United States (US) in the 1990s and spread rapidly in the community to become the leading cause of SSTIs in US urban emergency departments by 2004 [12]. USA300, which has also spread to many other parts of the world [13, 14], is MLST ST8 and usually carries SCCmec type IV, the phage-encoded Panton-Valentine leukocidin (PVL), and the arginine catabolic mobile element (ACME) [15, 16]. The genetic factors underlying the meteoric success of this strain type are not completely understood but it is likely that enhanced virulence promoting transmission, tolerance of the human body to its presence as a commensal, and an apparently limited fitness cost of its antibiotic resistance [17] are important. Only a few studies have suggested that USA300 can stably colonize patients for more than 6 months, but these have been limited by using genotyping methods that lack the genetic resolution to distinguish between persistent colonization by a strain and acquisition of a new colonizing strain from a different lineages within the same sequence type [18]. However, two recent studies have used whole genome sequencing to demonstrate the persistence of single USA300 clones to cause recurrent infections in individuals [19, 20].

There have now been a number of comparative genomics studies on USA300 MRSA. These have included studies using the fine scale resolving power of genomics to characterize the global population structure [13, 14, 21,22,23] and transmission patterns between patients [24, 25], within households [26,27,28] and in recurrent SSTIs [19]. In this work we explored the genetic diversity of USA300 on the bodies of subjects during a year of surveillance after an initial, clinically significant USA300 MRSA infection. In individual subjects within a prospective cohort, we set out to determine whether a single USA300 clonal lineage persisted after an infection, whether it persisted on or spread among three body sites, and how the genome changed during the year of observation.

Strain isolation and phenotypic testing

169 adult and pediatric (< 16 years of age) patients with a first known MRSA infection at any anatomic site were enrolled at the University of Chicago Medical Center (UCMC) in a longitudinal study of risk factors for recurrent MRSA infections between April 2012 and February 2014. The MRSA isolate from the site of infection is hereafter called the “initial infection isolate”. Subjects underwent an enrollment visit within 60 days of culture of their initial infection (time 1) when they were tested for S. aureus colonization of the nares, throat, and perirectal region. Subjects returned approximately one year later and were again cultured at the same 3 sites (time 2). Overnight broth enrichment culture (tryptic soy broth with 7% NaCl at 37 °C) was used to isolate S. aureus from colonization culture swabs. The broth was then plated on selective colorimetric solid media (Chromagar S. aureus) to initially screen for the presence of S. aureus, and the species was confirmed by the presence of the signature spa gene by PCR[29]. All S. aureus isolates, including the initial infection isolate and up to a single isolate obtained from each colonization culture, were frozen at − 80 °C. All of these isolates (up to 7 from each subject) underwent genotyping by MLST (expecting ST8 for USA300), PCR for the presence of the PVL genes, and, for MRSA isolates, SCCmec typing (expecting type IV for USA300). These are standard markers for identification of most USA300 MRSA strains [16]. All strains produced hemolytic clear zones on blood agar plates. Initial infection isolates were phenotypically tested for susceptibility to clindamycin, erythromycin, gentamicin, linezolid, methicillin, rifampin, tetracycline, trimethoprim-sulfamethoxazole and vancomycin. A medical record review was performed to determine the site of the initial MRSA infection and to determine if a true infection was present [30], the therapy used to treat infection, demographics, and comorbidities. Each subject was administered a detailed survey to assess risk factors for MRSA infection (Additional file 1).

All 31 subjects among the 169 enrolled subjects who had an ST8 MRSA initial infection isolate and one or more ST8 S. aureus isolates obtained from colonization cultures at one or both colonization culture visits were studied (n = 31/169, 18.3%). Three of the initial infection isolates were lost, leaving 28 of these isolates from 31 patients. 93 isolates (initial infection and colonization) from these 31 subjects underwent genomic preps and Illumina sequencing.

Illumina sequencing

Genomic preps were prepared with the DNeasy Blood and Tissue Kit (Qiagen, Germantown, MD). Libraries for sequencing 93 strains were constructed using Nextera technology (Illumina, Inc., San Diego, CA). Libraries were sequenced on an Illumina HiSeq instrument using either 100 nt or 125 nt paired-end protocols.

Sequence data analysis

Two strains had less than 100× predicted genome coverage (assuming an average 2.9 Mbp chromosome sequence). For consistency, all other genomes were downsampled to 100× coverage before assembly using a custom script (https://gist.github.com/rpetit3/9c623454758c9885bf81d269e3453b76) based on the seqtk toolkit (https://github.com/lh3/seqtk). Three strains were found not to be ST8 by genome-based MLST and were not included in subsequent analysis. Strains were assembled de novo using SPAdes [31] and annotated using Prokka [32]. Antibiotic resistance phenotypes were predicted for each strain based on the methods of Gordon et al. [33]. SnpEff 4.2 [34] was used to annotate SNPs in the VCF output of the parsnp alignment based on USA300_TCH1516 (NCBI RefSeq accession NC_010079.1; isolated from a pediatric patient at the Texas Children’s Hospital before 2007 [35]) coordinates. SNPs were mapped back on the shortened alignment using R BioStrings [36]. USA300_TCH1516 proteins were mapped to their orthologs in the S. aureus type strain NCTC8325 [37] using blastp [38], and gene ontology enrichment was performed using PANTHER [39] in December 2016.

A whole genome alignment of all the newly sequenced USA300 genomes was performed using Parsnp v1.2 [40] against the closed reference genome USA300_TCH1516. The Snippy pipeline [https://github.com/tseemann/snippy] was used to cross-validate SNPs predicted by Parsnp and to identify frameshifts and small indels. Plasmid content was found to be variable between strains (discussed below), and therefore not useful for comparisons across the whole dataset. One strain (an initial infection isolate) fell outside of the USA300 subgroup and was therefore excluded from the rest of the study, leaving a total of 89 strains. Due to these exclusions (see Additional files for a summary diagram), 2 patients were not represented by any samples, and we therefore concentrated our analysis on the 29 remaining patients, 28 of whom had an USA300 initial infection isolate. From the Parsnp alignment of the 89 strains, we extracted a core region of the USA300 chromosome of 2471 kbp (86%). The 14% of the chromosome excluded because it was missing in at least one of the genomes included SCCmec, ACME, the SaP15 pathogenicity islands, and the SLT and βC prophages [35]. Other regions not part of the core alignment were plasmids, rRNA operons, transposons, portions of membrane proteins and non-genic repeats.

The concatenated common aligned portion (2471,416 of the 2,872,915 bp [86%] USA300_TCH1516 reference [Additional file 2]) was used as the input for the recombination detection program ClonalFrameML v1.0–19-g9488a80 [41], along with a maximum likelihood guide tree produced by RAxML [42] v7.2.8. We removed 10,884 bp from the alignment identified by ClonalFrameML [41] as possibly of recombinant origin and then used as input for a maximum likelihood phylogeny under the GTRGAMMA model with 100 bootstraps using RAxML. Noisy (v1.5.12) [43] was used to scan for potentially homoplasious sites in the alignment. The sequences of the inner nodes of the phylogeny were reconstructed using FastML [44], based on the post-ClonalFrameML trimmed alignment. The R ape [45] dna.dist function was used to find the number of SNPs between leaves and ancestral nodes of the tree based on Hamming distance.

To identify integrated prophages, we aligned PCR primer sequences from seven diverse classes of S. aureus Siphovirus integrase [46] using blastn (version 2.3.0)[38], with the ‘blastn-short’ task option. To identify plasmid contigs, we aligned against a database of 230 complete S. aureus plasmids downloaded from NCBI using the blastn ‘megablast’ option. The contigs were also aligned against sequences from a Gram positive plasmid replicon typing scheme [47], identifying plasmid replicon [47] matches with blastn (task = blastn-short, cutoff = 1 mismatch or gap, match of 19 bases or more).

Raw sequence data were deposited at NCBI SRA under BioProject accession PRJNA388087.

Association of Subject Characteristics with persistence of an intra-subject lineage (ISL) of S. aureus

We defined an ISL as a cluster of isolates isolated from a patient that derived from a recent last common ancestor suggestive of a transmission bottleneck. Based on analysis of the data (described in the Results), members of an ISL isolated all shared < 30 SNPs in their core genome regions. We performed univariate testing (chi square, Fisher exact, Wilcoxon rank-sum or t-tests) to determine if subject characteristics (see list in  Additional file 1) were associated with colonization with an ISL (see discussion of ISL below) after initial infection at time 1 and time 2. We used Bonferroni correction to compensate for multiple comparisons.

Colonizing ST8 S. aureus strains can be isolated 12 months following initial infection

We isolated and sequenced 89 novel USA300 strains from 29 subjects who presented with a ST8 MRSA infection and were subsequently found to have at least a single ST8 S. aureus isolate obtained from a colonization culture at ≥1 of the 3 tested body sites at time 1 (enrollment) or time 2 (12 months) (Additional file 3). One strain, derived from a single, randomly chosen colony on the culture plate, was selected to represent each time and body site. Study subjects received 0–6 (median 1, interquartile range [IQR], 1–2) antibiotic drugs during treatment for the index infection (Additional file 1). S. aureus initial infection isolates (i.e., cultured from the site of infection) were retained prospectively for further study and underwent whole genome sequencing. Nose, throat and perirectal body sites were cultured at time 1, and S. aureus was isolated from 16, 15 and 17 patients, respectively. Approximately 12 months after the initial visit (time 2), we isolated S. aureus from 6, 3 and 4 subjects from nose, throat and perirectal sites, respectively (Table 1 and Additional files 1 and 3). While all initial infection isolates were obtained from suspected sites of infection, on review of the medical record, 2 were found to be obtained from sites of colonization and did not require treatment.

Phylogeny of USA300 isolates from Chicago patients reflect history of the local epidemic

The phylogeny of the core region of the 89 USA300 strains (Fig. 1) was composed of clades of leaf nodes with short branches near the tips, mostly representing isolates from individual patients, separated by relatively long branches in the middle section. In the deepest parts of the tree, branches were shorter and had lower bootstrap confidence. This pattern, seen in other genome-based studies of USA300 [26, 27] reflected the history of the epidemic [48]. USA300 spread rapidly after its introduction in the 1990s and achieved a large population size. USA300 then persisted in the community, causing sporadic clinically significant infections. By rooting the tree with the TCH1516 reference, a group of strains with mutations in gyrA and grlA predicted to confer ciprofloxacin resistance fell into a late-branching subgroup. The later development of resistance to fluoroquinolones was in line with results from analysis of the global population of USA300 [13, 22, 26, 27].

Maximum Likelihood tree of USA300 strains sequenced in the project. Orange triangles are branches with > 80–100% bootstrap support. Tips of trees are labelled by site of isolation (black = index infection isolate (III), green = throat, blue = nose, red = perirectal). Light colors are from sampling time 1, dark colors from sampling time 2. A color code and patient number were assigned to each patient. The squares on the outer ring represent antimicrobial class resistance predicted by the genome sequence. The figure was drawn using iTOL software [74]

Full size image

USA300 strains form “intra-subject lineages” (ISLs) present on multiple anatomic sites of a Subject’s body

As mentioned above, in most cases, the strains isolated from one subject clustered into a monophyletic group with shorter branch lengths than strains from other patients. We termed these groups ISLs, and we inferred that all strains within them derived from a single recent transmission bottleneck. The initial infection isolate from one subject (29) was lost during the course of the study, and we treated the remaining strains as outside of an ISL. Based on the phylogeny we removed six strains from ISLs because they were obviously phylogenetically unrelated to the other strains in the ISL. Five subjects (10,15,17,23,26) had colonizing strains from a different ISL than the initial infection isolate, suggesting colonization with more than one USA300 lineage. After removing these non-conforming strains, we were left with 23 subjects with an ISL that included an initial infection isolate and at least one other body site isolate.

Of the 23 patients with a USA300 ISL, 15, 11, and 15 (54, 39 and 50%) at the time 1 (enrollment) visit had an an isolate from the same ISL in the nose, throat and perirectal area, respectively. Following up one year later (i.e., time 2), 6 (21%) patients still had a strain from the same ISL in the nose, and 3 (11%) each in the throat in the perirectal area (Additional file 3). Strains were isolated at time 2 in 9 of the of original 23 ISLs (Table 1). Fourteen subjects had > 1 body site colonized by a strain from within an ISL at enrollment (time 1); only 2 subjects were colonized at > 1 body site with an ISL a year later.

In univariate analyses, after Bonferroni correction, we found that no tested subject characteristics, including age, sex, type of insurance coverage, race, treatment of the index infection with clindamycin, with vancomycin or with trimethoprim-sulfamethoxazole, or pet exposure (see complete list in Additional file 1) were significantly associated with colonization with an ISL after index infection at time 1 or time 2.

Genetic distance between and within ISLs

For each strain we calculated the number of SNPs between every other strain in another ISL and compared it to the number of SNPs within an ISL (Fig. 2). Strains in different patients had from 48 to 162 SNP differences (median = 106). The range for strains in the same ISL was 0 to 26 (median = 5).

Distribution of the number of SNPs separating strains within the same intra-subject lineage (ISL) compared with other strains

Full size image

The intra-ISL relationships were further analyzed by measuring the number of SNPs between each strain and the initial infection isolate (Fig. 3). There was no significant pattern to the number of SNPs differing in the initial infection isolate and each of the 3 tested body sites (ANOVA p = 0.8). The ranges for each body site were: nose, 0–22 (median 4.5), throat, 0–19 (median 7) and perirectal 0–26 (median 3.5). As expected, within host analysis showed that there were a significantly greater number of SNPs within ISLs between the initial infection isolate and strains from time 2 (range 2–26: median 10) compared with time 1 (range 0–12: median 3) (t-test, P < 7.8e-7).

Number of SNPs separating the initial infection isolate and strains within the same intra-subject lineage (ISL) at different sites. Horizontal lines in the box show the median, and box hinges are the 25th and 75th quartile. The upper whisker extends from the hinge to the largest value no further than 1.5 * interquartile range (IQR) from the hinge. The lower whisker extends from the hinge to the smallest value at most 1.5 * IQR of the hinge

Full size image

We used FastML [44] to reconstruct the sequence of internal nodes of the phylogeny and then found the number of SNPs differing between each strain of an ISL and its most recent common ancestor (MRCA). There was a significantly greater number of SNPs from the MRCA at time 2 (median = 9.5; interquartile range [IQR] = 7–14.5) compared with time 1 (median = 2; IQR = 1–4) (t-test, p < 7.7 e-13) (Fig. 4a). There was no significant difference in the number of SNPs between the initial infection isolate or other body sites at time 1 (ANOVA, p = 0.95), or at the 3 body sites sampled at time 2 (ANOVA, p = 0.49) (Fig. 4b and c).

Number of SNPs between the most recent common ancestor (MRCA) and strains at each sampling time point: a aggregated for each time point. Sampling time point 2 was approximately 1 year after time point 1. b at time point 1 between the MRCA and each body site. c at time point 2 between the MRCA and each body site (note difference in y-axis scale between B and A/C)

Full size image

Shifts in Mobile genetic element composition within ISLs

In S. aureus changes in accessory gene content mediated by prophage, genome island insertion and plasmid transfer are important mechanisms for genome evolution. However, tracking these changes is problematic using short read shotgun data. Loss or gain of a single element might affect dozens of genes at once, and plasmids and prophages undergo frequent recombination and share common sequences, making identification difficult [49]. Nevertheless we were able to use previously developed typing schemes to gain insights into changes in mobile element composition during colonization of the studied subjects.

For prophages, we used the scheme of Goerke et al., who defined 7 distinct sequence types of S. aureus integrase (Sa1–7) [46]. Presence of the each class was called based on BLAST matches of at least one of the integrase-specific primers. Most strains had Sa2 (87/89; 98%) and Sa3 (86/89; 96%) family prophages. These correspond to the ɸSa2 (ɸSLT) and ɸSa3 (ɸBC) prophages in the USA300_TCH1516 reference genome, respectively [35]. In addition, 40/89 (45%) strains had a Sa5 integrase gene. Eight strains (9%), all from patients 13 and 15, carried an Sa1 integrase. The patterns of prophage carriage mirror those described in USA300 by Jamrozy et al. [22], with the exception that we did not identify the rarer ɸSa7 prophages in our samples. We noted four occurrences of prophage composition change within an ISL (Additional file 3). These were the apparent loss of ɸSa3 in the initial infection isolate of subject 18 and the first throat culture of subject 15 and the apparent gain of ɸSa5 in the first perirectal isolate of subject 10 and the initial infection isolate of subject 16 (although based on its deep branching, the initial infection isolate may represent a separate colonization event from other strains isolated from subject 16).

To examine plasmid content we used the combination of BLAST alignments against DNA sequences from the Gram positive replicon typing scheme of Lozano et al. [47] and 344 complete Staphylococcus spp. plasmid sequences downloaded from NCBI (Additional file 3). All genomes contained the common backbone region of the 27 kb antibiotic-resistance plasmid of TCH1516, pUSA300HOUMR (NC_010063) [35]. 67/89 (72%) strains matched against > 25 kb of the plasmid, the rest contained subsequences of the plasmid as small as 13 kb that all contained the pN315-like replicon [50]. Eight strains contained the backbone of the 37 kb pUSA03 [51] multidrug resistant conjugative plasmid sequence but with the mupA gene missing (mupA encodes an altered isoleucyl-tRNA synthetase that confers mupirocin resistance). In the Jamrozy et al. study, in contrast to our findings, 146/154 (95%) USA300 strains from SSTIs carried the pUSA300HOUMR backbone plasmids and 5% (8/154) carried pUSA03-like plasmids. Families of smaller (< 10 kb) plasmids were present in some of our strains. The cryptic pUSA01 plasmid was found in 57 (64%) strains; pC194-like plasmids [52] were found in 6; 4 strains carried a plasmid with tetracycline-resistance gene tetK similar to the pUSA02 plasmid [51] (NC_007791); and there were 3 and 1 strains with plasmid replicons of the pUB110 [53] and pWG745 [54] families, respectively. Nine ISLs had strains with different plasmid content (patients 1, 2,6,7,8,9,11,12,16; Fig. 1). Plasmid content was not linked to a particular body site or sampling time point.

Predicted antibiotic resistance variation within ISLs

We observed that strains within several ISLs varied in their antibiotic resistance profile, based on the genomic predictions using the method of Gordon et al. [33]. Phenotypic susceptibility data for the index infection isolates is shown in Additional file 4. The first throat isolate of subject 15 was predicted to be ciprofloxacin resistant through gyrA/grlA mutations. This isolate was not part of the same ISL as the initial infection, nose and perirectal isolates from subject 15 (Fig. 1), and therefore it was not possible to determine whether the mutations occurred during colonization of subject 15 or earlier. Subject 15 was an outpatient who received only clindamycin during treatment of the index infection.

Two subjects had strains containing a 4.5 kb plasmid > 99% similar to pT181 [55] (NC_001371.1) and pUSA02 [51] (NC_007791), with the tetK tetracycline-resistance determinant. One of these was the initial infection isolate of subject 17, which was in a different ISL from the other strain isolated from this person (Fig. 1). From subject 12, the initial infection isolate and 2 other strains contained the tetK plasmid, but the nose strain did not. Either the strain originally infecting the subject was tetracycline-resistant and the nose isolate had been cured of the plasmid, or the plasmid was acquired by the ancestor of the three tetracycline-resistant strains. Both scenarios could be considered equally parsimonious as they require one plasmid gain/loss event. Neither subject 12 nor 17 were recorded as being treated with a tetracycline.

In subject 29, who was not treated with a β-lactam antibiotic for the index infection, the nose isolate had lost its blaZ gene owing to a deletion. The throat isolate from subject 29 was identical in its core chromosome sequence and had a plasmid with no deletion. In two subjects, strains switched from MRSA to MSSA because of deletion of the SCCmec cassette, which included the mecA gene. In subject 4 the index infection isolate was MRSA but all three strains isolated at time 2 (the 1-year visit) were MSSA. For subject 1, the situation was reversed. The index infection isolate was MSSA, but the colonizing strains isolated were all MRSA. The most parsimonious explanation was loss of the genes in the ancestor of the initial infection isolate shortly after colonization of the subject. Neither subject 1 nor 4 was treated with a β-lactam antibiotic for the index infection.

SNP patterns do not show signatures of strong positive selection within ISLs

Of the 1882 SNPs in core regions, 1494 (79%) were in genes and of these, 1101 (73%) caused non-synonymous or premature termination changes. This high percentage of mutations affecting amino acid sequences is typical when comparing closely related bacteria before purifying selection has time to operate [56] and has been reported previously in studies comparing USA300 strains [19, 22]. The non-synonymous changes fell over 787 genes. Using a Poisson test, we did not find a significant deviation from the number of mutations that would be expected based on the gene length, if the mutations were occurring randomly across the genome. The gene with most changes was USA300HOU_1372, encoding an extracellular binding protein precursor (ebp) with 27 mutations; this protein is also the largest in the genome (10,421 amino acids). USA300HOU_0192 encoding a non-ribosomal peptide synthase (2397 aa), had the second most changes with 7 mutations. Most mutations were only found in one strain and more than 95% were found in 7 or fewer genomes. This was a result of the sampling strategy employed in the study, where a maximum of seven strains was taken from the same subject (one initial infection isolate plus up to one isolate colonizing each of 3 body sites at 2 time points). Mutations that occurred frequently were those found only in the reference (and hence common to all 89 strains sequenced here), in deeper branches of the tree, and those causing ciprofloxacin resistance.

We were interested to determine if there were any patterns in terms of the function of genes that acquired SNPs only in a certain body site, as it was possible that there was tissue-dependent selection that may act over multiple genes linked by common phenotype. We found 50, 190, 187 and 246 SNPs unique to nose, perirectal area, throat and initial infection isolate, respectively. Using PANTHER [39] we looked for pathways in the Gene Ontology enriched for genes affected by terminations and non-synonymous mutations at each site but found no significant results after multiple hypothesis correction.

Deletions in Agr and ACME/SCCmec/ɸSa2 deletions within ISLs

We found that chromosomal indels reshaped virulence and resistance elements in the initial infection isolates and in the colonization strains. ACME is a 31 kb mobile genetic element that may be important for the success of North American USA300 strains [57] (although it absent from South American strains) [21]. Eleven strains in this study were found to have a deleted ACME and one partially deleted. In 6 subjects, the ACME element appears to have been lost by strains within the ISL (assuming the MRCA of the ISL was ACME+). In subject 25, who was treated with trimethoprim-sulfamethoxazole for the index infection, all strains were deleted in their ACME element and also lost their flanking SCCmec cassette, making them MSSA. Two strains isolated from the perirectal region of subject 20 were missing the ɸSa2 prophage carrying the PVL lukSF genes. These accessory genes are postulated to be important for SSTIs caused by USA300 (discussed in [58]).

We also noted that 5 strains contained frameshift mutations in the agr regulatory locus that would theoretically render them less capable of causing toxin-mediated tissue damage [59, 60] (Additional file 3). However, these strains and all others isolated for this study were hemolytic when grown on blood agar plates, suggesting that these mutations did not completely disrupt the system. Two strains from subject 26 (initial infection isolate and first throat isolate) that were not part of the same ISL had frameshift mutations in different portions of the agrC gene. Three of six strains from subject 11, on a monophyletic branch of the ISL phylogeny carried the same frameshift in the agrA gene encoding the regulatory protein, suggesting a single mutation event. This suggested that functional products of agr were not necessary for long-term survival on patients. Also, the mutant strains were isolated at both timepoints in all three body sites, thus demonstrating that S. aureus strains had migrated among anatomic sites on this subject.

In this study we showed that S. aureus USA300 ISLs, defined as having < 30 SNPs over 86% of the chromosome from the common ancestor, asymptomatically colonized a patient for more than a year after a confirmed or suspected infection. This cutoff is arbitrary and not meant to define an absolute limit but it is line with numbers of SNPs per year reported in other recent studies of S. aureus carriage. Young et al. [61] sequenced 68 nasal and blood isolates from a MSSA clone in one patient over 6 months, finding a total of 30 SNPs in all isolates. Sabat et al. reported that there were a maximum of 8 SNPs difference between USA300 isolated at the same time from different body sites of patients during a USA300 outbreak in Suriname [25]. Our finding here of temporal stability within a single USA300 lineage for a year or more also echoes the result of the shotgun metagenomic study of Oh et al. [62], who found that strain-specific SNPs for another human colonizing Staphylococcus species, S. epidermidis, could be recovered at the same skin sites at sampling times 1–2 years apart. Some subjects were colonized with more than one ISL: in 5 of the 29 subjects, we isolated USA300 from different lineages, and in 2 we isolated colonizing isolates that were not USA300 (one was another ST8, the other was ST6).

There have been few prior studies of longitudinal carriage of MRSA with whole genome sequencing to assess persistence of clonal carriage. To the best of our knowledge, there have been no previous such studies in which multiple body sites have been tested along with genome sequencing of an initial infecting isolate. In addition, comparison of S. aureus ISLs at different body sites over time is also novel in the literature. These data have therefore enabled us to perform a number of novel analyses on clonal variation within ISLs.

For example, we found that only a median of 2 SNPs separated the ISL isolates from the predicted MRCA sequence (Fig. 4a). The small number of SNPs suggested a short time period after the transmission bottleneck event, which may be a feature of the high virulence of USA300 [58]. Multiple genome-based studies have estimated the S. aureus mutation rate to be between 1.3–3.3 × 10^− 6 SNPs per genome per year [26, 63,64,65,66], or approximately 1 SNP every 9 weeks [2]. Based on this estimate, the median time from MRCA to first time point (time 1) strains would have been a median of about 18 weeks with an IQR of 9–36 weeks. However, because of the limited isolate sampling, this timing is likely an underestimate. When the same patient was sampled a year later (time 2), the chance of culturing an ISL isolate was lower than time 1, which suggested that asymptomatic carriage was declining. Comparison of the positions on the ISL phylogeny of strains from the first and second time point for strain isolation indicated that it was possible that strains may have moved between or among body sites. These results also suggested that the nose, throat and perirectal area were approximately equally efficient at maintaining S. aureus colonization. Other studies have come to different conclusions, pointing to particular anatomic sites as potentially more important for long-term colonization than others, for example the anterior nares or the oropharynx [67, 68]. This finding challenges the traditional assumption that the anterior nares is the site of long-term carriage in colonized subjects. However, additional studies, sampling patients over longer time periods, are needed to understand the typical lifecycle of an ISL on a human subject. This information, in turn, may be important in the design of decolonization studies and regimens.

We did not identify a specific gene or locus that acquired an unusual number of SNPs suggestive of positive selection. With the number of genomes in our study, we had limited power to detect parallel mutations, especially those that may have been associated with adaptation specifically to the anatomic niches of the nose, throat or perirectal region. We did, however, encounter a significant number of genetic changes associated with movements of mobile elements during the history of colonization, including phage and plasmid gain and loss and loss of ACME and SCCmec elements. The latter two are particularly significant as they are considered central to the success of the USA300 MRSA clone, although naturally occurring deleted strains are not infrequently isolated [13, 22, 69]. We also encountered agr mutant strains, as have others who have studied S. aureus colonization [19, 59, 70]. These mutants may be evolutionary dead ends if transmission to new hosts preferentially selects for ACME+, SCCmec + and agr + strains.

This study had a number of limitations. Due to sampling design we were constrained to sequencing one colony at each anatomic site/time point and could not estimate the extent of within-strain variation on a single host [71]. In this regard, recent studies have shown that rare variants within a population can be important in tracking transmission among hosts [72, 73]. We also did not track colonization of household contacts, and therefore we do not know what role re-transmission among individuals played in prolonging the apparent colonization of an individual.

We have used comparative genomics to sketch out some of the features of S. aureus asymptomatic, longitudinal colonization of humans. There are many unanswered questions related to the evolution of S. aureus during colonization, transmission and disease. We do not know how long an ISL persists on individuals nor how effective various classes of systemic antibiotics are in reducing colonization. We know that individual clones persist for years in households, but there may be expansion of a reservoir with frequent transfer of strains between individuals and fomites [26, 27]. We do not know which body site is the most common source for transmission between carriers or between carriers and fomites and where on the body there are more likely to be transitions between colonizing and infecting S. aureus. It would also be invaluable to compare the S. aureus strain to the background skin microbiome in order to start to investigate the source of selective pressure to lose or gain genetic elements such as SCCmec and the selective pressure leading to persistence or loss of S. aureus colonization. Future research that address these questions will support the development of interventions to prevent S. aureus infections in susceptible people.

Using genome sequencing we were able to plausibly define USA300 S. aureus ISLs. We showed colonization of USA300 after an index USA300 MRSA infection of a patient for up to a year. Persistently colonizing strains could be found in all anatomic sites tested: nose, throat, and perirectal area. We showed that colonization by USA300, including MSSA and MRSA, was less prevalent when sampled more than a year after an initial infection. During the course of colonization there were changes in plasmid and prophage content and antibiotic resistance, including loss the SCCmec cassette to create MSSA strains. Using similar genome-based approaches but with more intensive sampling, it may be possible to define evolutionary constraints giving rise to bottlenecks emerging after exposure to antimicrobials and to determine the natural history of asymptomatic colonization of people by pathogenic S. aureus strain types as well as perhaps their risk of recurrent infection.

ACME:

arginine catabolic mobile element

ISL:

intra-subject lineage

MLST:

multilocus sequence type

MRCA:

most recent common ancestor

MRSA:

methicillin resistant S. aureus

MSSA:

methicillin sensitive S. aureus

PVL:

Panton-Valentine leukocidin

SSTI:

skin and soft tissue infection

We would like to thank Michael Frisch for help formatting the sequence data for NIH submission.

Funding

TDR was supported by NIH grant AI121860; MZD was supported by NIH grant AI095361–01. The funder had no role in the design of the study; in the collection, interpretation, or analysis of the data; nor in the writing of the manuscript.

Availability of data and materials

The datasets generated and/or analysed during the current study are available in the NCBI SRA repository under bioproject accession https://www.ncbi.nlm.nih.gov/bioproject/PRJNA388087/. An interactive tree with metadata is available at http://itol.embl.de/tree/1701401041483411505410590.

Affiliations

1. Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA
   • Timothy D. Read
   •  & Robert A. Petit III
2. Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA
   • Timothy D. Read
   •  & Robert A. Petit III
3. Department of Pediatrics, Section of Infectious Diseases, University of Chicago, Chicago, IL, USA
   • Zachary Yin
   •  & Tuyaa Montgomery
4. Department of Medicine, Section of Infectious Diseases and Global Health, University of Chicago, Chicago, IL, USA
   • Moira C. McNulty
5. Department of Medicine, Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA, USA
   • Michael Z. David

Contributions

TDR performed bioinformatics analysis and wrote the manuscript. RAP performed bioinformatic analysis. ZY processed cultures and performed MLST and PCR genotyping studies on S. aureus isolates. TM collected, tested for hemolysis, and froze infecting isolates. MCM recorded much of the clinical data from the medical records. MZD designed and directed the clinical portions of the study, provided funding for whole genome sequencing and edited the manuscript. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Michael Z. David.

Ethics approval and consent to participate

The study was approved by the Institutional Review Board of the Division of the Biological Sciences of the University of Chicago (protocol 11–0222) and written informed consent was obtained from each subject. For pediatric patients, consent for enrollment was obtained from a parent or guardian.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reprints and Permissions